Respiratory care devices are those medical instruments that are used for the diagnosis, monitoring, and care of patients who are suffering from various respiratory diseases. Major devices such as oxygen concentrator, ventilators, inhalers, nebulizers, spirometers, positive airway pressure (PAP) are primarily used for respiratory disease’s diagnostic, therapeutic, and monitoring. Introduction of innovative product launches and high adoption of cutting edge technology and integration of digital and sensor based technologies for creating a smart, portfolio, and connected respiratory care devices will further aid the growth of the market.
The growth of the market is attributed to the increasing prevalence of infectious respiratory diseases, rapidly increasing cases of asthma and COPD, rising number of product launches and approvals, and growing R & D investment for respiratory care devices. However, cutthroat competition among market players and unfavorable reimbursement scenarios hampers the respiratory care devices market growth.Infectious respiratory diseases are creating a rising burden on the healthcare system worldwide. Infectious respiratory disease can be induced due to several factors associated with immune deficiency. Most infectious respiratory diseases are spread from person to person through mucus and saliva and are caused by microorganisms that can infect the respiratory system. The severity of contagious respiratory diseases ranges from mild to severe. Infectious respiratory diseases consist of an exhaustive list of diseases, such as tuberculosis (TB), COVID-19, influenza, diphtheria, measles, pneumonia, pertussis, and respiratory syncytial virus (RSV), etc.
Among the above-mentioned infectious respiratory diseases, TB was on the top of the list for high prevalence before the COVID-19 pandemic.
The respiratory care devices market is segmented based on product, indication, end user, and geography.
Based on product, the market is segmented into therapeutic devices, monitoring devices, diagnostics devices, and consumables & accessories. The therapeutic devices segment is further subsegmented into positive airway pressure (PAP) devices, oxygen concentrators, ventilators, inhalers, nebulizers, humidifiers, and others. The positive airway pressure (PAP) devices segment is subsegmented into CPAP devices, APAP devices, and BiPAP devices. The oxygen concentrators segment is subsegmented into fixed oxygen concentrators and portable oxygen concentrators. The inhalers segment is subsegmented into metered dose inhalers and dry powder inhalers. The monitoring devices segment is segmented into pulse oximeters, capnography, and gas analyzers. The diagnostics devices segment is subsegmented into spirometers, polysomnography devices, peak flow meters, and other diagnostic devices. The consumables & accessories segment is further subsegmented into masks, disposable resuscitators, tracheostomy tubes, breathing circuits, and other consumables & accessories.
Based on indication, the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others.